SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of EHang Holdings Limited (NASDAQ: EH) publicly traded securities between January 20, 2022 and November 6, 2023, inclusive (the “Class Period”), have until February 2, 2024 to seek appointment as lead plaintiff of the EHang class action lawsuit. Captioned Pujo v. EHang Holdings Limited, No. 23-cv-10165 (C.D. Cal.), the EHang class action lawsuit charges EHang and certain of its top current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the EHang class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-ehang-holdings-limited-class-action-lawsuit-eh.html
You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.
CASE ALLEGATIONS: EHang describes itself as an autonomous aerial vehicle technology company.
The EHang class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) EHang has continued to state that it was partnering with United Therapeutics, DHL, and Vodafone, among others, even though a former EHang employee has noted that United Therapeutics, DHL, and Vodafone have abandoned their respective deals with EHang; and (ii) EHang omitted that other entities that had placed pre-orders for its aircraft, such as Prestige Aviation and Shenzhen Boling Holding Group, did not engage in regular business in the aviation sector and are otherwise almost certainly not in a financial position to be able to afford their orders.
The EHang class action lawsuit further alleges that on November 7, 2023 Hindenburg Research released a report entitled “EHang: Hollow Order Book And Fake Sales Make This China-Based eVTOL Company Last In Line For Takeoff.” On this news, the price of EHang American Depository Shares declined by nearly 13%, the EHang class action lawsuit alleges.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired EHang publicly traded securities during the Class Period to seek appointment as lead plaintiff of the EHang class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the EHang class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the EHang class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the EHang class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller is one of the world’s leading complex class action firms representing plaintiffs in securities fraud cases. The Firm is ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report for recovering more than $1.75 billion for investors in 2022 – the third year in a row Robbins Geller tops the list. And in those three years alone, Robbins Geller recovered nearly $5.3 billion for investors, more than double the amount recovered by any other plaintiffs’ firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Contact:
Robbins Geller Rudman & Dowd LLP
655 W. Broadway, Suite 1900, San Diego, CA 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com
- Kelly Benefits (Kelly & Associates) Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims - April 22, 2025
- Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025 - April 22, 2025
- ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS - April 22, 2025
